Skip to main content

McKesson Value Stock - Dividend - Research Selection

Mckesson

ISIN: US58155Q1031 , WKN: 893953

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Why the Market Dipped But McKesson (MCK) Gained Today

2026-01-30
In the closing of the recent trading day, McKesson (MCK) stood at $831.21, denoting a +1.08% move from the preceding trading day.

Unlocking Q3 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics

2026-01-30
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.

With 90% institutional ownership, McKesson Corporation (NYSE:MCK) is a favorite amongst the big guns

2026-01-30
Key Insights Significantly high institutional ownership implies McKesson's stock price is sensitive to their trading...

McKesson Corporation Completes Divestiture of Norwegian Operations

2026-01-30
IRVING, Texas, January 30, 2026--McKesson Corporation (NYSE: MCK) announced today that it has closed the transaction to sell its retail and distribution businesses in Norway to NorgesGruppen, a privately owned retail group.

McKesson Corporation Declares Quarterly Dividend

2026-01-28
IRVING, Texas, January 28, 2026--The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on April 1, 2026, to shareholders of record on March 2, 2026.

IBD Stock Of The Day: Why Cardinal Health's Momentum Is 'Special' — And Not Over Yet

2026-01-26
Cardinal Health is Monday's IBD Stock Of The Day. Shares are rebounding off their 21-day line, helped by continued biopharma momentum.

Assessing McKesson (MCK) Valuation After Mixed Short-Term Returns And Strong Long-Term Gains

2026-01-24
Why McKesson (MCK) is on investors’ radar today McKesson (MCK) is drawing attention after recent share price moves, with the stock last closing at US$820.23 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for McKesson. While the 7 day share price return of 2.41% and the 30 day return of 0.75% suggest some recent cooling in momentum around the latest close at US$820.23, the 1 year total shareholder return of 39.24% and 5 year total shareholder...

HCI Announces SPARK HR 2026 in St. Pete Beach, FL on April 28-30, 2026: A Transformative Conference on Employee Experience, Leadership & the Future of Work

2026-01-23
The Human Capital Institute (HCI) is proud to announce SPARK HR 2026, a premier HR leadership conference taking place April 28–30, 2026, at the TradeWinds Resort in St. Pete Beach, Florida.

Coating Place Announces Leadership Appointments to Support Next Phase of Growth

2026-01-23
As Coating Place celebrates its 50th anniversary, the company continues to build on its long-standing reputation as the industry leader in Wurster-based fluid bed technology for controlled release and taste masking applications.

Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical and Align Technology

2026-01-23
McKesson, Cardinal Health, West Pharmaceutical, and Align Technology are set to benefit from innovation, aging populations, and rising medical supply demand in 2026.